...
首页> 外文期刊>Current Drug Targets >GPR40 Carboxylic Acid Receptor Family and Diabetes: A New Drug Target
【24h】

GPR40 Carboxylic Acid Receptor Family and Diabetes: A New Drug Target

机译:GPR40羧酸受体家族和糖尿病:一种新的药物靶标

获取原文
获取原文并翻译 | 示例

摘要

Type-2 diabetes is strongly linked to visceral obesity and elevated levels of circulating free fatty acids. For years this correlation of obesity to diabetes has intrigued the minds of researchers and research in this direction has led to a possible solution to this question. Human Genome project has identified nearly 150 orphan GPCRs. The reverse pharmacology approaches have identified free fatty acids as ligands for the GPR40 family of orphan receptors. This review mainly emphasizes on the role of GPR40 carboxylic acid receptor family in the development of diabetes alongwith detailed coverage of each receptor of the family. GPR40 family has provided an insight into regulation of carbohydrate and lipid metabolism in vertebrates and has further provided targets for the development of therapeutic agents useful for treating or preventing disorders such as Type-2 diabetes. This review also suggests where further research and development could be beneficial.
机译:2型糖尿病与内脏肥胖和循环游离脂肪酸水平升高密切相关。多年来,肥胖与糖尿病之间的这种联系一直引起研究人员的兴趣,并且朝着这个方向进行的研究已导致对该问题的可能解决方案。人类基因组计划已鉴定出近150个孤儿GPCR。反向药理学方法已鉴定出游离脂肪酸是孤儿受体GPR40家族的配体。这篇综述主要强调了GPR40羧酸受体家族在糖尿病发展中的作用,以及该家族每个受体的详细报道。 GPR40家族提供了脊椎动物中碳水化合物和脂质代谢调控的见解,并进一步为开发可用于治疗或预防疾病(如2型糖尿病)的治疗剂提供了靶点。这篇评论还提出了进一步研究和开发在哪些方面可能是有益的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号